|
Volumn 13, Issue 4, 1998, Pages 257-269
|
Design of lysosomotropic macromolecular prodrug of doxorubicin using N-acetyl-α-1,4-polygalactosamine as a targeting carrier to hepatoma tissue
a a a a b b b c d d d |
Author keywords
[No Author keywords available]
|
Indexed keywords
BIODEGRADATION;
CHEMOTHERAPY;
CONTROLLED DRUG DELIVERY;
DERIVATIVES;
DRUG PRODUCTS;
ONCOLOGY;
CHITOSAN;
DRUG CARRIERS;
PRODRUGS;
CHITIN;
DOXORUBICIN;
DRUG CARRIER;
PRODRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG CONJUGATION;
DRUG DESIGN;
DRUG RELEASE;
DRUG TARGETING;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER CELL CARCINOMA;
MALE;
MOUSE;
NONHUMAN;
SUBCUTANEOUS DRUG ADMINISTRATION;
SURVIVAL TIME;
TISSUE DISTRIBUTION;
|
EID: 0032189471
PISSN: 08839115
EISSN: None
Source Type: Journal
DOI: 10.1177/088391159801300402 Document Type: Article |
Times cited : (4)
|
References (21)
|